On adaptive mechanisms of crizotinib resistance in ALK-positive lung cancer - http://pharmastrategyblog.com/2012...
Mar 23, 2012
from
Sally Church
Interested in Pharma, Biotech, Science and cancer... Find me at http://www.pharmastrategyblog.com also love food, wine, the NFL and cricket. Hi!
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR : Nature : Nature Publishing Group - http://www.nature.com/nature...
Mar 11, 2012
from
Colon cancer patients harbouring BRAF(V600E) oncogenic lesion have poor prognosis and show only a very limited response to vemurafenib, despite it being effective for melanoma. Why?
- Sally Church
J&J unblind Zytiga phase 3 trial in pre-chemotherapy castrate-resistant prostate cancer - http://pharmastrategyblog.com/2012...
Mar 8, 2012
from
The importance of metabolism in cancer research - http://pharmastrategyblog.com/2012...
Mar 6, 2012
from
nab-Paclitaxel and its potential role in pancreatic cancer - http://pharmastrategyblog.com/2012...
Mar 5, 2012
from
Video Report from 2012 European Association of Urology Congress in Paris - http://pharmastrategyblog.com/2012...
Mar 2, 2012
from
We the People… - http://pharmastrategyblog.com/2012...
Feb 29, 2012
from
The challenge of prostate cancer drug approval versus reimbursement - http://pharmastrategyblog.com/2012...
Feb 27, 2012
from
Will combining custirsen and MDV3100 reduce resistance in advanced prostate cancer? - http://pharmastrategyblog.com/2012...
Feb 26, 2012
from
Combined VEGF and MET inhibition in some cancers may be better than either alone - http://pharmastrategyblog.com/2012...
Feb 24, 2012
from
Cancer Clinical Trials: Companion Diagnostics or Gene Sequencing? - http://pharmastrategyblog.com/2012...
Feb 21, 2012
from
Raised platelets reduce survival in ovarian cancer - http://pharmastrategyblog.com/2012...
Feb 15, 2012
from
A new fusion gene target in a rare soft tissue sarcoma - http://pharmastrategyblog.com/2012...
Feb 14, 2012
from
The role of the Androgen Receptor in breast cancer - http://pharmastrategyblog.com/2012...
Feb 10, 2012
from
Is ARN-509 (Aragon) potentially better than MDV-3100 (Medivation) in advanced prostate cancer? - http://pharmastrategyblog.com/2012...
Feb 2, 2012
from
Update on Medivation’s MDV3100 in advanced prostate cancer - http://pharmastrategyblog.com/2012...
Jan 31, 2012
from
On KRAS, NF-kB activation and pancreatic cancer - http://pharmastrategyblog.com/2012...
Jan 31, 2012
from
FDA approves Roche hedgehog inhibitor vismodegib/Erivedge in basal cell carcinoma - http://pharmastrategyblog.com/2012...
Jan 30, 2012
from
A new opportunity for vemurafenib in BRAFV600E colon cancer - http://pharmastrategyblog.com/2012...
Jan 26, 2012
from
Unravelling early colorectal cancer: the links between ROS, DNA methylation and inflammatory responses - http://pharmastrategyblog.com/2012...
Jan 24, 2012
from
New research demonstrates the link between inflammation and early development of colon cancer - http://pharmastrategyblog.com/2012...
Jan 23, 2012
from
RNAi as a potential biomarker for early breast cancer - http://pharmastrategyblog.com/2012...
Jan 16, 2012
from
Gene mutation and resistance to chemotherapy in colorectal cancer - http://pharmastrategyblog.com/2012...
Jan 5, 2012
from
ASH 2011 Update #3 – Multiple Myeloma - http://pharmastrategyblog.com/2012...
Jan 4, 2012
from
AVEO announces front-line data in renal cell cancer for tivozanib - http://pharmastrategyblog.com/2012...
Jan 3, 2012
from
I+just+entered+to+win+a+personal+assistant+for+a+whole+year+%28worth+%2410%2C400%21%29+Enter+here%3A - http://http%3a%2f%2fbit.ly%2fu6zadr/
Dec 26, 2011
from
ASH 2011 Update #2 – Non Hodgkins Lymphoma - http://pharmastrategyblog.com/2011...
Dec 21, 2011
from
ASH 2011 Update 1: Bruton’s Kinase Inhibitors (BTK) - http://pharmastrategyblog.com/2011...
Dec 15, 2011
from
What’s hot at SABCS – Update 2 – advanced breast cancer - http://pharmastrategyblog.com/2011...
Dec 10, 2011
from
Follow the American Society of Hematology ASH conversations! - http://pharmastrategyblog.com/2011...
Dec 10, 2011
from
What’s hot at the American Society of Hematology 2011? - http://pharmastrategyblog.com/2011...
Dec 10, 2011
from